Cash round sets up trial of InteRNA’s microRNA for cancerDutch biotech InteRNA Technologies has raised €18.5 million ($22 million) in second-round financing as it prepares to start Share XCash round sets up trial of InteRNA’s microRNA for cancerhttps://pharmaphorum.com/news/cash-round-sets-up-trial-of-internas-microrna-for-cancer/
